KATIE SIMPSON: Open Payments
NPI 1922373760 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 19 payments from 12 companies in 2025. Trend: 2023 $447 · 2024 $461 · 2025 $423
Food & beverage: $388Education: $35
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Travere Therapeutics, Inc. | 2 | $28 |
| Procept Biorobotics Corporation | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $23 |
| Telix Pharmaceuticals | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: GEMTESA, Fabhalta, IMFINZI, TARPEYO, AQUABEAM ROBOTIC SYSTEM, PURIFIED CORTROPHIN GEL, Optilume BPH Drug Coated Balloon Catheter, ILLUCCIX.
Industry payments across NY — which companies pay providers there.
